BIMI International Medical (BIMI) Key Ratios
$0.00
$0.00 (0.00%)As on 11-Sep-2026 09:30EDT
Market cap
$0 Mln
Revenue (TTM)
$6 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -54.44 | -65.38 | -65.64 | 54.36 | -1.97 |
| EBIT | -- | -37.30 | 18.35 | -194.60 | -216.27 |
| Net Profit | -385.86 | 22.41 | 41.77 | -193.10 | -245.24 |
| EPS | -389.41 | 54.32 | 37.63 | 19.90 | 10.91 |
| Book Value | -- | -- | -18.34 | 4.71 | -64.46 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-22 | Dec-21 |
| EBIT-Margin
| -110.11 | -308.05 | -180.34 | -153.77 | -151.13 |
| Net Margin
| -39.53 | 267.40 | -425.27 | -- | -- |
| Return on equity
| -195.43 | -144.81 | -304.83 | -293.85 | -250.76 |
| Return on Capital
| -118.26 | -91.53 | -- | -152.19 | -167.92 |
| Return on Assets
| -58.49 | -48.85 | -46.50 | -60.65 | -98.10 |
| Debt to Equity (x)
| -- | -- | 0.00 | 1.35 | 0.78 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
ROE
-304.83
Lower than Peers by 323.80
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
-304.83
|
-293.85
|
-250.76
|
-41.69
|
-47.56
|
-90.17
|
|||||
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
--
|
ROA
-46.50
Lower than Peers by 49.36
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
-46.50
|
-60.65
|
-98.10
|
-16.73
|
-16.72
|
-52.06
|
|||||
|
Peer Median
|
2.86
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
-180.34
Lower than Peers by 196.16
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
-180.34
|
-153.77
|
-151.13
|
-25.43
|
-968.49
|
-241.41
|
|||||
|
Peer Median
|
15.82
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-425.27
Lower than Peers by 433.50
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
-425.27
|
-189.29
|
-164.10
|
-39.53
|
1,133.55
|
-291.83
|
|||||
|
Peer Median
|
8.23
|
--
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
Revenue Growth
-65.64
Lower than Peers by 73.69
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
-65.64
|
-0.45
|
0.66
|
80.31
|
-0.98
|
-0.23
|
|||||
|
Peer Median
|
8.05
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
18.35
Higher than Peers by 10.09
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
18.35
|
43.54
|
-886.25
|
-113.53
|
90.31
|
-1,192.44
|
|||||
|
Peer Median
|
8.26
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
41.77
Higher than Peers by 34.04
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
41.77
|
35.99
|
-560.93
|
-19.25
|
73.56
|
-969.20
|
|||||
|
Peer Median
|
7.73
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
37.63
Higher than Peers by 27.23
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
37.63
|
-0.45
|
0.74
|
-32.11
|
0.78
|
0.80
|
|||||
|
Peer Median
|
10.39
|
--
|
--
|
--
|
--
|
--
|
Book Value Growth
-49.70
Lower than Peers by 54.57
Year on year growth in book value per share
Solvency
Debt to Equity
0.00
Lower than Peers by 0.60
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
0.00
|
1.35
|
0.78
|
0.30
|
0.01
|
0.58
|
|||||
|
Peer Median
|
0.60
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.23
--
(Short term borrowings / Net worth)
Current Ratio
1.21
Lower than Peers by 0.44
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
1.21
|
0.92
|
0.96
|
1.62
|
1.02
|
0.20
|
|||||
|
Peer Median
|
1.65
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
0.86
Lower than Peers by 0.34
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
0.86
|
0.61
|
0.72
|
1.57
|
0.99
|
0.13
|
|||||
|
Peer Median
|
1.20
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-2.82
Lower than Peers by 7.59
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
-2.82
|
-5.30
|
-13.19
|
-38.48
|
-241.06
|
-37.93
|
|||||
|
Peer Median
|
4.77
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
92.24
Higher than Peers by 70.96
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
92.24
|
35.29
|
28.49
|
64.92
|
6.39
|
20.49
|
|||||
|
Peer Median
|
21.27
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.11
Lower than Peers by 0.29
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
0.11
|
0.32
|
0.60
|
0.41
|
0.01
|
0.20
|
|||||
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
Inventory Days
--
--
Average Inventory / Sales * 365
Payable days
--
--
Average Creditors / Cost of goods sold * 365
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
--
|
-0.21
|
-0.12
|
-0.11
|
-6.66
|
-7.10
|
|||||
|
Peer Median
|
36.38
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
0.00
Lower than Peers by 7.57
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
Dec-15
|
Dec-14
|
Dec-13
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
0.00
|
1.14
|
0.39
|
0.03
|
3.41
|
11.93
|
|||||
|
Peer Median
|
7.57
|
--
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
EV/EBITDA
-2.66
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
Market Cap
0
Lower than Peers by 2,569
Current Share price multiplied by latest total number of shares outstanding